| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| ILLUMINA, INC. | Director | Common Stock | 6,455 | $498,455 | $77.22 | 21 May 2025 | Direct |
| EXELON CORP | Director | Common stock- deferred stock units | 10,372 | $455,019 | $43.87 | 31 Dec 2025 | By Exelon Corp. Directors Deferred Stock Unit Plan |
| EXELON CORP | Director | Deferred phantom share equivalents | 7,863 | $342,748 | $43.59 | 31 Dec 2025 | Direct |
| Adamas Pharmaceuticals Inc | Director | Common Stock | 0 | $5.16 | 24 Nov 2021 | Direct | |
| Adamas Pharmaceuticals Inc | Director | Stock Option (Right to Buy) | 0 | 24 Nov 2021 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| EXC | EXELON CORP | 31 Dec 2025 | 2 | +$72,492 | 4 | Director | 02 Jan 2026, 15:07 |
| EXC | EXELON CORP | 30 Sep 2025 | 2 | +$72,495 | 4 | Director | 01 Oct 2025, 20:46 |
| EXC | EXELON CORP | 30 Jun 2025 | 2 | +$72,479 | 4 | Director | 02 Jul 2025, 09:39 |
| ILMN | ILLUMINA, INC. | 21 May 2025 | 1 | $0 | 4 | Director | 23 May 2025, 17:05 |
| EXC | EXELON CORP | 31 Mar 2025 | 2 | +$72,472 | 4 | Director | 02 Apr 2025, 14:26 |
| EXC | EXELON CORP | 31 Dec 2024 | 2 | +$72,499 | 4 | Director | 03 Jan 2025, 10:38 |
| EXC | EXELON CORP | 30 Sep 2024 | 2 | +$72,500 | 4 | Director | 02 Oct 2024, 13:29 |
| EXC | EXELON CORP | 30 Jun 2024 | 2 | +$72,515 | 4 | Director | 02 Jul 2024, 16:02 |
| ILMN | ILLUMINA, INC. | 16 May 2024 | 1 | $0 | 4 | Director | 22 May 2024, 17:22 |
| ILMN | ILLUMINA, INC. | 16 May 2024 | 0 | $0 | 3 | Director | 22 May 2024, 17:12 |
| EXC | EXELON CORP | 31 Mar 2024 | 2 | +$72,480 | 4 | Director | 02 Apr 2024, 14:07 |
| EXC | EXELON CORP | 31 Dec 2023 | 2 | +$72,482 | 4 | Director | 02 Jan 2024, 20:50 |
| EXC | EXELON CORP | 30 Sep 2023 | 2 | +$47,720 | 4 | Director | 02 Oct 2023, 18:36 |
| EXC | EXELON CORP | 01 Aug 2023 | 0 | $0 | 3 | Director | 02 Aug 2023, 15:10 |
| /report/000132814321000088-richo-anna-2021-11-24 | Adamas Pharmaceuticals Inc | 24 Nov 2021 | 3 | $0 | 4 | Director | 24 Nov 2021, 15:08 |
| /report/000132814321000061-richo-anna-2021-06-02 | Adamas Pharmaceuticals Inc | 02 Jun 2021 | 2 | $0 | 4 | Director | 04 Jun 2021, 16:17 |